×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
PHARMACOVIGILANCE AND MEDICINAL PRODUCT STANDARDS AND METADATA
Session Chair(s)
Andrew Marr, PhD
Managing Director
Marr Consultancy Ltd, United Kingdom
From XEVMPD to IDMP
Learning Objective : How to move from XEVMPD to IDMP Differences and Pitfalls when moving to IDMP
Speaker(s)
XEVMPD Experience to Date - The ongoing activities and the future towards IDMP
John Kiser, MSc
Kiser Regulatory Services, United States
Principal
From XEVMPD to IDMP
Christian Kravogel, MS
EXTEDO Gmbh, Germany
Managing Consultant
Transitioning to IDMP – Challenges and Opportunities
Andrew Marr, PhD
Marr Consultancy Ltd, United Kingdom
Managing Director
Have an account?